Safety and efficacy of remote electrical neuromodulation for the acute treatment of chronic migraine: an open-label study
Safety and efficacy of remote electrical neuromodulation for the acute treatment of chronic migraine: an open-label study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Safety and efficacy of remote electrical neuromodulation for the acute treatment of chronic migraine: an open-label study have?
Safety and efficacy of remote electrical neuromodulation for the acute treatment of chronic migraine: an open-label study has 31 citations in the OpenAlex counts ScholarIQ stores.
When was Safety and efficacy of remote electrical neuromodulation for the acute treatment of chronic migraine: an open-label study published?
Safety and efficacy of remote electrical neuromodulation for the acute treatment of chronic migraine: an open-label study has 2021 year in the ScholarIQ index.
What is the open-access status of Safety and efficacy of remote electrical neuromodulation for the acute treatment of chronic migraine: an open-label study?
Safety and efficacy of remote electrical neuromodulation for the acute treatment of chronic migraine: an open-label study has gold oa status in the ScholarIQ index.
What is the DOI of Safety and efficacy of remote electrical neuromodulation for the acute treatment of chronic migraine: an open-label study?
The DOI for Safety and efficacy of remote electrical neuromodulation for the acute treatment of chronic migraine: an open-label study is on the source record.
What is the PMID of Safety and efficacy of remote electrical neuromodulation for the acute treatment of chronic migraine: an open-label study?
The PMID for Safety and efficacy of remote electrical neuromodulation for the acute treatment of chronic migraine: an open-label study is on the source record.
What is the OpenAlex record for Safety and efficacy of remote electrical neuromodulation for the acute treatment of chronic migraine: an open-label study?
The OpenAlex for Safety and efficacy of remote electrical neuromodulation for the acute treatment of chronic migraine: an open-label study is on the source record.